Agilon Health (NYSE:AGL) Stock Price Down 9.9% – Time to Sell?

Shares of Agilon Health, Inc. (NYSE:AGL) fell 9.9% during mid-day trading on Thursday . The company traded as low as $87.09 and last traded at $97.1780. 106,539 shares traded hands during trading, a decline of 70% from the average session volume of 352,914 shares. The stock had previously closed at $107.85.

Analyst Ratings Changes

A number of analysts have weighed in on AGL shares. Barclays set a $111.00 target price on shares of Agilon Health and gave the company an “equal weight” rating in a research report on Thursday. Weiss Ratings downgraded shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Robert W. Baird set a $116.00 price target on Agilon Health in a research note on Thursday. Benchmark reissued a “buy” rating and set a $140.00 price objective (up from $95.00) on shares of Agilon Health in a report on Thursday. Finally, Truist Financial set a $112.00 price objective on Agilon Health and gave the stock a “hold” rating in a research report on Thursday. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Agilon Health presently has an average rating of “Hold” and a consensus price target of $84.82.

Agilon Health Price Performance

The company’s 50 day moving average price is $106.82 and its 200-day moving average price is $55.98. The stock has a market cap of $1.63 billion, a P/E ratio of -6.79 and a beta of 3.01. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 122.70%. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. As a group, sell-side analysts expect that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Institutional Investors Weigh In On Agilon Health

Institutional investors have recently made changes to their positions in the stock. LPL Financial LLC increased its stake in shares of Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after buying an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new position in shares of Agilon Health in the fourth quarter worth approximately $34,000. CIBC Bancorp USA Inc. bought a new stake in Agilon Health in the third quarter valued at approximately $34,000. Merit Financial Group LLC bought a new stake in Agilon Health in the fourth quarter valued at approximately $35,000. Finally, Focus Partners Advisor Solutions LLC acquired a new stake in Agilon Health during the 4th quarter valued at approximately $53,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.